320 related articles for article (PubMed ID: 30885099)
1. Synthesis and characterization of heterobimetallic Sn
Afzal M; Usman M; Al-Lohedan HA; Tabassum S
J Biomol Struct Dyn; 2020 Mar; 38(4):1130-1142. PubMed ID: 30885099
[TBL] [Abstract][Full Text] [Related]
2. Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}.
Afsan Z; Roisnel T; Tabassum S; Arjmand F
Bioorg Chem; 2020 Jan; 94():103427. PubMed ID: 31735357
[TBL] [Abstract][Full Text] [Related]
3. Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα.
Tabassum S; Asim A; Khan RA; Hussain Z; Srivastav S; Srikrishna S; Arjmand F
Dalton Trans; 2013 Dec; 42(48):16749-61. PubMed ID: 24077532
[TBL] [Abstract][Full Text] [Related]
4. New heterobimetallic Cu(II)-Sn2(IV) complex as potential topoisomerase I inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines.
Tabassum S; Afzal M; Arjmand F
J Photochem Photobiol B; 2012 Oct; 115():63-72. PubMed ID: 22884481
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structures, nuclease activity, cytotoxicity, DFT and molecular docking studies of two nitrato bridged homodinuclear (Cu-Cu, Zn-Zn) complexes containing 2,2'-bipyridine and a chalcone derivative.
Gaur R; Choubey DK; Usman M; Ward BD; Roy JK; Mishra L
J Photochem Photobiol B; 2017 Aug; 173():650-660. PubMed ID: 28711020
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, spectroscopic and biological activity evaluation of Ni(II), Cu(II) and Zn(II) complexes of schiff base derived from pyridoxal and 4-fluorobenzohydrazide.
Kavitha R; Reddy CVR; Sireesha B
Nucleosides Nucleotides Nucleic Acids; 2021; 40(8):845-866. PubMed ID: 34379029
[TBL] [Abstract][Full Text] [Related]
7. Water soluble Cu(II) and Zn(II) complexes of bidentate-morpholine based ligand: synthesis, spectral, DFT calculation, biological activities and molecular docking studies.
Senthilkumar GS; Sankarganesh M; Dhaveethu Raja J; Adwin Jose PR; Sakthivel A; Christopher Jeyakumar T; Nandini Asha R
J Biomol Struct Dyn; 2022 Feb; 40(3):1074-1083. PubMed ID: 32936064
[TBL] [Abstract][Full Text] [Related]
8. Revelation of potential bioactive water-soluble Boc-L-valine and imidazole appended metal complexes {M = Co(II), Cu(II) & Zn(II)}: synthesis, characterization, ct-DNA binding, pBR322 cleavage, SOD mimetic, and cytotoxicity studies.
Akhter S; Khursheed S; Arjmand F; Tabassum S
Dalton Trans; 2023 Apr; 52(16):5141-5154. PubMed ID: 36961247
[TBL] [Abstract][Full Text] [Related]
9.
Alasbahy WM; Shamsi M
J Biomol Struct Dyn; 2022; 40(22):11484-11494. PubMed ID: 34351843
[No Abstract] [Full Text] [Related]
10. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
Tabassum S; Zaki M; Afzal M; Arjmand F
Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and in vitro DNA binding and cleavage studies of Cu(II)/Zn(II) dipeptide complexes.
Arjmand F; Jamsheera A; Mohapatra DK
J Photochem Photobiol B; 2013 Apr; 121():75-85. PubMed ID: 23518161
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate-based heteronuclear complexes as topoisomerase Iα inhibitor: approach toward anticancer chemotherapeutics.
Afzal M; Al-Lohedan HA; Usman M; Tabassum S
J Biomol Struct Dyn; 2019 Apr; 37(6):1494-1510. PubMed ID: 29606083
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular structure, biological properties and molecular docking studies on Mn(II), Co(II) and Zn(II) complexes containing bipyridine-azide ligands.
Thamilarasan V; Jayamani A; Sengottuvelan N
Eur J Med Chem; 2015 Jan; 89():266-78. PubMed ID: 25462243
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands.
Anupama B; Aruna A; Manga V; Sivan S; Sagar MV; Chandrashekar R
J Fluoresc; 2017 May; 27(3):953-965. PubMed ID: 28097460
[TBL] [Abstract][Full Text] [Related]
15. Ni(ii)/Cu(ii)/Zn(ii) 5,5-diethylbarbiturate complexes with 1,10-phenanthroline and 2,2'-dipyridylamine: synthesis, structures, DNA/BSA binding, nuclease activity, molecular docking, cellular uptake, cytotoxicity and the mode of cell death.
Yilmaz VT; Icsel C; Suyunova F; Aygun M; Aztopal N; Ulukaya E
Dalton Trans; 2016 Jun; 45(25):10466-79. PubMed ID: 27263797
[TBL] [Abstract][Full Text] [Related]
16. Molecular drug design, synthesis and crystal structure determination of CuII-SnIV heterobimetallic core: DNA binding and cleavage studies.
Arjmand F; Parveen S; Afzal M; Toupet L; Ben Hadda T
Eur J Med Chem; 2012 Mar; 49():141-50. PubMed ID: 22305542
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structures, molecular docking, cytotoxicity and bioimaging studies of two novel Zn(II) complexes.
Gao E; Sun N; Zhang S; Ding Y; Qiu X; Zhan Y; Zhu M
Eur J Med Chem; 2016 Oct; 121():1-11. PubMed ID: 27214507
[TBL] [Abstract][Full Text] [Related]
18. Spectroscopic, Computational, Antimicrobial, DNA Interaction, In Vitro Anticancer and Molecular Docking Properties of Biochemically Active Cu(II) and Zn(II) Complexes of Pyrimidine-Ligand.
Sankarganesh M; Dhaveethu Raja J; Adwin Jose PR; Vinoth Kumar GG; Rajesh J; Rajasekaran R
J Fluoresc; 2018 Jul; 28(4):975-985. PubMed ID: 29961205
[TBL] [Abstract][Full Text] [Related]
19. New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity.
Zehra S; Shavez Khan M; Ahmad I; Arjmand F
J Biomol Struct Dyn; 2019 Apr; 37(7):1863-1879. PubMed ID: 29676660
[TBL] [Abstract][Full Text] [Related]
20. Bio-active mixed ligand Cu(II) and Zn(II) complexes of pyrimidine derivative Schiff base: DFT calculation, antimicrobial, antioxidant, DNA binding, anticancer and molecular docking studies.
Revathi N; Sankarganesh M; Dhaveethu Raja J; Vinoth Kumar GG; Sakthivel A; Rajasekaran R
J Biomol Struct Dyn; 2021 May; 39(8):3012-3024. PubMed ID: 32329409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
